Last 12 months
Inside the activity.
0 purchase rows · 93 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 0 | 6 |
| Dec 2025 | 0 | 16 |
| Jan 2026 | 0 | 2 |
| Feb 2026 | 0 | 49 |
| Mar 2026 | 0 | 5 |
| Apr 2026 | 0 | 1 |
| May 2026 | 0 | 6 |
| Jun 2026 | 0 | 5 |
| Jul 2026 | 0 | 3 |
| Aug 2026 | 0 | 0 |
| Sep 2026 | 0 | 0 |
| Oct 2026 | 0 | 0 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| August 15, 2022 Filed Aug 17, 2022 21:39 UTC |
Arbuckle Stuart AEVP, COO
|
SaleCommon Stock | 400 | $302.55 | $121,020.00 |
DisclosureSEC source: 0000899243-22-029030 · doc4.xml · nonDerivative · entry 4 Arbuckle Stuart A · CIK 0001557290 · EVP, COO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 61,555 F1 · kind: Transaction made pursuant to Mr. Arbuckle's company approved trading plan under Rule 10b5-1. F2 · price: Mr. Arbuckle undertakes to provide (upon request by the SEC staff, the Issuer or a security holder of the Issuer) full information regarding the number of shares sold at each separate price. F5 · price: Open market sales reported on this line occurred at a weighted average price of $302.55 (range $302.13 to $302.90). Read SEC document |
| August 15, 2022 Filed Aug 17, 2022 21:39 UTC |
Arbuckle Stuart AEVP, COO
|
SaleCommon Stock | 4,242 | $301.61 | $1,279,429.62 |
DisclosureSEC source: 0000899243-22-029030 · doc4.xml · nonDerivative · entry 3 Arbuckle Stuart A · CIK 0001557290 · EVP, COO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 61,955 F1 · kind: Transaction made pursuant to Mr. Arbuckle's company approved trading plan under Rule 10b5-1. F2 · price: Mr. Arbuckle undertakes to provide (upon request by the SEC staff, the Issuer or a security holder of the Issuer) full information regarding the number of shares sold at each separate price. F4 · price: Open market sales reported on this line occurred at a weighted average price of $301.61 (range $301.09 to $302.01). Read SEC document |
| August 15, 2022 Filed Aug 17, 2022 21:39 UTC |
Arbuckle Stuart AEVP, COO
|
SaleCommon Stock | 1,254 | $300.30 | $376,576.20 |
DisclosureSEC source: 0000899243-22-029030 · doc4.xml · nonDerivative · entry 2 Arbuckle Stuart A · CIK 0001557290 · EVP, COO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 66,197 F1 · kind: Transaction made pursuant to Mr. Arbuckle's company approved trading plan under Rule 10b5-1. F2 · price: Mr. Arbuckle undertakes to provide (upon request by the SEC staff, the Issuer or a security holder of the Issuer) full information regarding the number of shares sold at each separate price. F3 · price: Open market sales reported on this line occurred at a weighted average price of $300.30 (range $300.00 to $300.73). Read SEC document |
| August 15, 2022 Filed Aug 17, 2022 21:39 UTC |
Arbuckle Stuart AEVP, COO
|
Exercise / conversionCommon Stock | 6,571 | $155.57 | $1,022,250.47 |
DisclosureSEC source: 0000899243-22-029030 · doc4.xml · nonDerivative · entry 1 Arbuckle Stuart A · CIK 0001557290 · EVP, COO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 67,451 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| August 15, 2022 Filed Aug 17, 2022 21:40 UTC |
Kewalramani ReshmaDirector · CEO & President
|
SaleCommon Stock | 11,689 | $305.06 | $3,565,846.34 |
DisclosureSEC source: 0000899243-22-029032 · doc4.xml · nonDerivative · entry 1 Kewalramani Reshma · CIK 0001735944 · Director · CEO & President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 99,598 F1 · kind: Transaction made pursuant to Dr. Kewalramani's company approved trading plan under Rule 10b5-1. F2 · price: Dr. Kewalramani undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price. F3 · price: Open market sales reported on this line occurred at a weighted average price of $305.06 (range $305.00 to $305.22). Read SEC document |
| August 10, 2022 Filed Aug 12, 2022 20:05 UTC |
Liu JoySVP, General Counsel
|
SaleCommon Stock | 36 | $300.32 | $10,811.52 |
DisclosureSEC source: 0000899243-22-028470 · doc4.xml · nonDerivative · entry 1 Liu Joy · CIK 0001847529 · SVP, General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 13,352 F1 · kind: Transaction made pursuant to Ms. Liu's company approved trading plan under Rule 10b5-1. Read SEC document |
| August 10, 2022 Filed Aug 12, 2022 20:05 UTC |
Arbuckle Stuart AEVP, COO
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 64 | $0.00 Strike: $155.57 | $0.00 |
DisclosureSEC source: 0000899243-22-028474 · doc4.xml · derivative · entry 5 Arbuckle Stuart A · CIK 0001557290 · EVP, COO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,571 Underlying: Common Stock · 64 shares Expires 2028-02-05 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: Fully vested. Read SEC document |
| August 10, 2022 Filed Aug 12, 2022 20:05 UTC |
Arbuckle Stuart AEVP, COO
|
SaleCommon Stock | 9 | $302.01 | $2,718.09 |
DisclosureSEC source: 0000899243-22-028474 · doc4.xml · nonDerivative · entry 3 Arbuckle Stuart A · CIK 0001557290 · EVP, COO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 60,880 F1 · kind: Transaction made pursuant to Mr. Arbuckle's company approved trading plan under Rule 10b5-1. Read SEC document |
| August 10, 2022 Filed Aug 12, 2022 20:05 UTC |
Arbuckle Stuart AEVP, COO
|
SaleCommon Stock | 171 | $300.32 | $51,354.72 |
DisclosureSEC source: 0000899243-22-028474 · doc4.xml · nonDerivative · entry 2 Arbuckle Stuart A · CIK 0001557290 · EVP, COO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 60,889 F1 · kind: Transaction made pursuant to Mr. Arbuckle's company approved trading plan under Rule 10b5-1. Read SEC document |
| August 10, 2022 Filed Aug 12, 2022 20:05 UTC |
Arbuckle Stuart AEVP, COO
|
Exercise / conversionCommon Stock | 64 | $155.57 | $9,956.48 |
DisclosureSEC source: 0000899243-22-028474 · doc4.xml · nonDerivative · entry 1 Arbuckle Stuart A · CIK 0001557290 · EVP, COO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 61,060 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| August 09, 2022 Filed Aug 10, 2022 20:06 UTC |
Arbuckle Stuart AEVP, COO
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 1,926 | $0.00 Strike: $155.57 | $0.00 |
DisclosureSEC source: 0000899243-22-028244 · doc4.xml · derivative · entry 5 Arbuckle Stuart A · CIK 0001557290 · EVP, COO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,635 Underlying: Common Stock · 1,926 shares Expires 2028-02-05 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F5 · derivative.exercise_date: Fully vested. Read SEC document |
| August 09, 2022 Filed Aug 10, 2022 20:06 UTC |
Arbuckle Stuart AEVP, COO
|
SaleCommon Stock | 900 | $301.42 | $271,278.00 |
DisclosureSEC source: 0000899243-22-028244 · doc4.xml · nonDerivative · entry 3 Arbuckle Stuart A · CIK 0001557290 · EVP, COO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 60,996 F1 · kind: Transaction made pursuant to Mr. Arbuckle's company approved trading plan under Rule 10b5-1. F2 · price: Mr. Arbuckle undertakes to provide (upon request by the SEC staff, the Issuer or a security holder of the Issuer) full information regarding the number of shares sold at each separate price. F4 · price: Open market sales reported on this line occurred at a weighted average price of $301.42 (range $301.13 to $301.61). Read SEC document |
| August 09, 2022 Filed Aug 10, 2022 20:06 UTC |
Arbuckle Stuart AEVP, COO
|
SaleCommon Stock | 4,790 | $300.53 | $1,439,538.70 |
DisclosureSEC source: 0000899243-22-028244 · doc4.xml · nonDerivative · entry 2 Arbuckle Stuart A · CIK 0001557290 · EVP, COO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 61,896 F1 · kind: Transaction made pursuant to Mr. Arbuckle's company approved trading plan under Rule 10b5-1. F2 · price: Mr. Arbuckle undertakes to provide (upon request by the SEC staff, the Issuer or a security holder of the Issuer) full information regarding the number of shares sold at each separate price. F3 · price: Open market sales reported on this line occurred at a weighted average price of $300.53 (range $300.00 to $300.84). Read SEC document |
| August 09, 2022 Filed Aug 10, 2022 20:06 UTC |
Arbuckle Stuart AEVP, COO
|
Exercise / conversionCommon Stock | 1,926 | $155.57 | $299,627.82 |
DisclosureSEC source: 0000899243-22-028244 · doc4.xml · nonDerivative · entry 1 Arbuckle Stuart A · CIK 0001557290 · EVP, COO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 66,686 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| August 09, 2022 Filed Aug 10, 2022 20:06 UTC |
Tatsis OuraniaEVP, Chief Reg. & Quality Off.
|
SaleCommon Stock | 74 | $301.67 | $22,323.58 |
DisclosureSEC source: 0000899243-22-028248 · doc4.xml · nonDerivative · entry 5 Tatsis Ourania · CIK 0001789815 · EVP, Chief Reg. & Quality Off. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 46,090 F2 · kind: Transaction made pursuant to Ms. Tatsis' company approved trading plan under Rule 10b5-1. Read SEC document |
| August 09, 2022 Filed Aug 10, 2022 20:06 UTC |
Tatsis OuraniaEVP, Chief Reg. & Quality Off.
|
SaleCommon Stock | 72 | $300.64 | $21,646.08 |
DisclosureSEC source: 0000899243-22-028248 · doc4.xml · nonDerivative · entry 4 Tatsis Ourania · CIK 0001789815 · EVP, Chief Reg. & Quality Off. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 46,164 F2 · kind: Transaction made pursuant to Ms. Tatsis' company approved trading plan under Rule 10b5-1. Read SEC document |
| August 09, 2022 Filed Aug 10, 2022 20:06 UTC |
Tatsis OuraniaEVP, Chief Reg. & Quality Off.
|
SaleCommon Stock | 283 | $299.79 | $84,840.57 |
DisclosureSEC source: 0000899243-22-028248 · doc4.xml · nonDerivative · entry 3 Tatsis Ourania · CIK 0001789815 · EVP, Chief Reg. & Quality Off. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 46,236 F2 · kind: Transaction made pursuant to Ms. Tatsis' company approved trading plan under Rule 10b5-1. F3 · price: Ms. Tatsis undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price. F6 · price: Open market sales reported on this line occurred at a weighted average price of $299.79 (range $299.44 to $300.33). Read SEC document |
| August 09, 2022 Filed Aug 10, 2022 20:06 UTC |
Tatsis OuraniaEVP, Chief Reg. & Quality Off.
|
SaleCommon Stock | 679 | $298.77 | $202,864.83 |
DisclosureSEC source: 0000899243-22-028248 · doc4.xml · nonDerivative · entry 2 Tatsis Ourania · CIK 0001789815 · EVP, Chief Reg. & Quality Off. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 46,519 F2 · kind: Transaction made pursuant to Ms. Tatsis' company approved trading plan under Rule 10b5-1. F3 · price: Ms. Tatsis undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price. F5 · price: Open market sales reported on this line occurred at a weighted average price of $298.77 (range $298.29 to $299.19). Read SEC document |
| August 09, 2022 Filed Aug 10, 2022 20:06 UTC |
Tatsis OuraniaEVP, Chief Reg. & Quality Off.
|
SaleCommon Stock | 292 | $297.54 | $86,881.68 |
DisclosureSEC source: 0000899243-22-028248 · doc4.xml · nonDerivative · entry 1 Tatsis Ourania · CIK 0001789815 · EVP, Chief Reg. & Quality Off. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 47,198 F2 · kind: Transaction made pursuant to Ms. Tatsis' company approved trading plan under Rule 10b5-1. F3 · price: Ms. Tatsis undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price. F4 · price: Open market sales reported on this line occurred at a weighted average price of $297.54 (range $297.00 to $297.80). F1 · balance_after: Includes 134 shares previously purchased under the issuer's Employee Stock Purchase Plan. Read SEC document |
| August 09, 2022 Filed Aug 10, 2022 20:06 UTC |
Liu JoySVP, General Counsel
|
SaleCommon Stock | 946 | $300.00 | $283,800.00 |
DisclosureSEC source: 0000899243-22-028249 · doc4.xml · nonDerivative · entry 1 Liu Joy · CIK 0001847529 · SVP, General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 13,388 F1 · kind: Transaction made pursuant to Ms. Liu's company approved trading plan under Rule 10b5-1. Read SEC document |
| August 08, 2022 Filed Aug 10, 2022 20:06 UTC |
ALTSHULER DAVIDEVP, Global Research and CSO
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 1,304 | $0.00 Strike: $187.53 | $0.00 |
DisclosureSEC source: 0000899243-22-028246 · doc4.xml · derivative · entry 7 ALTSHULER DAVID · CIK 0001550395 · EVP, Global Research and CSO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,607 Underlying: Common Stock · 1,304 shares Expires 2029-02-05 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F8 · derivative.exercise_date: The option vests in 16 quarterly installments from 2/6/2019. Read SEC document |
| August 08, 2022 Filed Aug 10, 2022 20:06 UTC |
ALTSHULER DAVIDEVP, Global Research and CSO
|
SaleCommon Stock | 146 | $295.14 | $43,090.44 |
DisclosureSEC source: 0000899243-22-028246 · doc4.xml · nonDerivative · entry 6 ALTSHULER DAVID · CIK 0001550395 · EVP, Global Research and CSO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 36,077 F1 · kind: Transaction made pursuant to Mr. Altshuler's company approved trading plan under Rule 10b5-1. F2 · price: Mr. Altshuler undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price. F7 · price: Open market sales reported on this line occurred at a weighted average price of $295.14 (range $294.74 to $295.53). Read SEC document |
| August 08, 2022 Filed Aug 10, 2022 20:06 UTC |
ALTSHULER DAVIDEVP, Global Research and CSO
|
SaleCommon Stock | 302 | $293.99 | $88,784.98 |
DisclosureSEC source: 0000899243-22-028246 · doc4.xml · nonDerivative · entry 5 ALTSHULER DAVID · CIK 0001550395 · EVP, Global Research and CSO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 36,223 F1 · kind: Transaction made pursuant to Mr. Altshuler's company approved trading plan under Rule 10b5-1. F2 · price: Mr. Altshuler undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price. F6 · price: Open market sales reported on this line occurred at a weighted average price of $293.99 (range $293.58 to $294.26). Read SEC document |
| August 08, 2022 Filed Aug 10, 2022 20:06 UTC |
ALTSHULER DAVIDEVP, Global Research and CSO
|
SaleCommon Stock | 210 | $293.02 | $61,534.20 |
DisclosureSEC source: 0000899243-22-028246 · doc4.xml · nonDerivative · entry 4 ALTSHULER DAVID · CIK 0001550395 · EVP, Global Research and CSO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 36,525 F1 · kind: Transaction made pursuant to Mr. Altshuler's company approved trading plan under Rule 10b5-1. F2 · price: Mr. Altshuler undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price. F5 · price: Open market sales reported on this line occurred at a weighted average price of $293.02 (range $292.41 to $293.36). Read SEC document |
| August 08, 2022 Filed Aug 10, 2022 20:06 UTC |
ALTSHULER DAVIDEVP, Global Research and CSO
|
SaleCommon Stock | 424 | $291.53 | $123,608.72 |
DisclosureSEC source: 0000899243-22-028246 · doc4.xml · nonDerivative · entry 3 ALTSHULER DAVID · CIK 0001550395 · EVP, Global Research and CSO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 36,735 F1 · kind: Transaction made pursuant to Mr. Altshuler's company approved trading plan under Rule 10b5-1. F2 · price: Mr. Altshuler undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price. F4 · price: Open market sales reported on this line occurred at a weighted average price of $291.53 (range $291.06 to $291.91). Read SEC document |
| August 08, 2022 Filed Aug 10, 2022 20:06 UTC |
ALTSHULER DAVIDEVP, Global Research and CSO
|
SaleCommon Stock | 222 | $290.32 | $64,451.04 |
DisclosureSEC source: 0000899243-22-028246 · doc4.xml · nonDerivative · entry 2 ALTSHULER DAVID · CIK 0001550395 · EVP, Global Research and CSO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 37,159 F1 · kind: Transaction made pursuant to Mr. Altshuler's company approved trading plan under Rule 10b5-1. F2 · price: Mr. Altshuler undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price. F3 · price: Open market sales reported on this line occurred at a weighted average price of $290.32 (range $290.05 to $290.64). Read SEC document |
| August 08, 2022 Filed Aug 10, 2022 20:06 UTC |
ALTSHULER DAVIDEVP, Global Research and CSO
|
Exercise / conversionCommon Stock | 1,304 | $187.53 | $244,539.12 |
DisclosureSEC source: 0000899243-22-028246 · doc4.xml · nonDerivative · entry 1 ALTSHULER DAVID · CIK 0001550395 · EVP, Global Research and CSO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 37,381 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| August 08, 2022 Filed Aug 10, 2022 20:07 UTC |
Bhatia Sangeeta N.Director
|
SaleCommon Stock | 47 | $295.53 | $13,889.91 |
DisclosureSEC source: 0000899243-22-028250 · doc4.xml · nonDerivative · entry 5 Bhatia Sangeeta N. · CIK 0001643921 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,661 F1 · kind: Transaction made pursuant to Dr. Bhatia's company approved trading plan under Rule 10b5-1. Read SEC document |
| August 08, 2022 Filed Aug 10, 2022 20:07 UTC |
Bhatia Sangeeta N.Director
|
SaleCommon Stock | 161 | $294.24 | $47,372.64 |
DisclosureSEC source: 0000899243-22-028250 · doc4.xml · nonDerivative · entry 4 Bhatia Sangeeta N. · CIK 0001643921 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,708 F1 · kind: Transaction made pursuant to Dr. Bhatia's company approved trading plan under Rule 10b5-1. F2 · price: Dr. Bhatia undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price. F6 · price: Open market sales reported on this line occurred at a weighted average price of $294.24 (range $293.85 to $294.49). Read SEC document |
| August 08, 2022 Filed Aug 10, 2022 20:07 UTC |
Bhatia Sangeeta N.Director
|
SaleCommon Stock | 204 | $293.15 | $59,802.60 |
DisclosureSEC source: 0000899243-22-028250 · doc4.xml · nonDerivative · entry 3 Bhatia Sangeeta N. · CIK 0001643921 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,869 F1 · kind: Transaction made pursuant to Dr. Bhatia's company approved trading plan under Rule 10b5-1. F2 · price: Dr. Bhatia undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price. F5 · price: Open market sales reported on this line occurred at a weighted average price of $293.15 (range $292.71 to $293.61). Read SEC document |
| August 08, 2022 Filed Aug 10, 2022 20:07 UTC |
Bhatia Sangeeta N.Director
|
SaleCommon Stock | 164 | $291.76 | $47,848.64 |
DisclosureSEC source: 0000899243-22-028250 · doc4.xml · nonDerivative · entry 2 Bhatia Sangeeta N. · CIK 0001643921 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,073 F1 · kind: Transaction made pursuant to Dr. Bhatia's company approved trading plan under Rule 10b5-1. F2 · price: Dr. Bhatia undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price. F4 · price: Open market sales reported on this line occurred at a weighted average price of $291.76 (range $291.59 to $291.91). Read SEC document |
| August 08, 2022 Filed Aug 10, 2022 20:07 UTC |
Bhatia Sangeeta N.Director
|
SaleCommon Stock | 45 | $290.18 | $13,058.10 |
DisclosureSEC source: 0000899243-22-028250 · doc4.xml · nonDerivative · entry 1 Bhatia Sangeeta N. · CIK 0001643921 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,237 F1 · kind: Transaction made pursuant to Dr. Bhatia's company approved trading plan under Rule 10b5-1. F2 · price: Dr. Bhatia undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price. F3 · price: Open market sales reported on this line occurred at a weighted average price of $290.18 (range $290.05 to $290.20). Read SEC document |
| August 01, 2022 Filed Aug 3, 2022 20:05 UTC |
Sanna BastianoEVP, Cell & Genetic Therapies
|
Tax withholdingCommon Stock | 766 | $276.62 | $211,890.92 |
DisclosureSEC source: 0000899243-22-027571 · doc4.xml · nonDerivative · entry 1 Sanna Bastiano · CIK 0001829069 · EVP, Cell & Genetic Therapies 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 40,983 Read SEC document |
| July 29, 2022 Filed Aug 2, 2022 20:16 UTC |
Bhatia Sangeeta N.Director
|
SaleCommon Stock | 5 | $282.34 | $1,411.70 |
DisclosureSEC source: 0000899243-22-027386 · doc4.xml · nonDerivative · entry 6 Bhatia Sangeeta N. · CIK 0001643921 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,282 F1 · kind: Transaction made pursuant to Dr. Bhatia's company approved trading plan under Rule 10b5-1. Read SEC document |
| July 29, 2022 Filed Aug 2, 2022 20:16 UTC |
Bhatia Sangeeta N.Director
|
SaleCommon Stock | 58 | $281.03 | $16,299.74 |
DisclosureSEC source: 0000899243-22-027386 · doc4.xml · nonDerivative · entry 5 Bhatia Sangeeta N. · CIK 0001643921 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,287 F1 · kind: Transaction made pursuant to Dr. Bhatia's company approved trading plan under Rule 10b5-1. F2 · price: Dr. Bhatia undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price. F7 · price: Open market sales reported on this line occurred at a weighted average price of $281.03 (range $280.93 to $281.08). Read SEC document |
| July 29, 2022 Filed Aug 2, 2022 20:16 UTC |
Bhatia Sangeeta N.Director
|
SaleCommon Stock | 99 | $280.22 | $27,741.78 |
DisclosureSEC source: 0000899243-22-027386 · doc4.xml · nonDerivative · entry 4 Bhatia Sangeeta N. · CIK 0001643921 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,345 F1 · kind: Transaction made pursuant to Dr. Bhatia's company approved trading plan under Rule 10b5-1. F2 · price: Dr. Bhatia undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price. F6 · price: Open market sales reported on this line occurred at a weighted average price of $280.22 (range $279.88 to $280.78). Read SEC document |
| July 29, 2022 Filed Aug 2, 2022 20:16 UTC |
Bhatia Sangeeta N.Director
|
SaleCommon Stock | 160 | $279.28 | $44,684.80 |
DisclosureSEC source: 0000899243-22-027386 · doc4.xml · nonDerivative · entry 3 Bhatia Sangeeta N. · CIK 0001643921 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,444 F1 · kind: Transaction made pursuant to Dr. Bhatia's company approved trading plan under Rule 10b5-1. F2 · price: Dr. Bhatia undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price. F5 · price: Open market sales reported on this line occurred at a weighted average price of $279.28 (range $278.86 to $279.83). Read SEC document |
| July 29, 2022 Filed Aug 2, 2022 20:16 UTC |
Bhatia Sangeeta N.Director
|
SaleCommon Stock | 200 | $277.95 | $55,590.00 |
DisclosureSEC source: 0000899243-22-027386 · doc4.xml · nonDerivative · entry 2 Bhatia Sangeeta N. · CIK 0001643921 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,604 F1 · kind: Transaction made pursuant to Dr. Bhatia's company approved trading plan under Rule 10b5-1. F2 · price: Dr. Bhatia undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price. F4 · price: Open market sales reported on this line occurred at a weighted average price of $277.95 (range $277.63 to $278.35). Read SEC document |
| July 29, 2022 Filed Aug 2, 2022 20:16 UTC |
Bhatia Sangeeta N.Director
|
SaleCommon Stock | 99 | $276.65 | $27,388.35 |
DisclosureSEC source: 0000899243-22-027386 · doc4.xml · nonDerivative · entry 1 Bhatia Sangeeta N. · CIK 0001643921 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,804 F1 · kind: Transaction made pursuant to Dr. Bhatia's company approved trading plan under Rule 10b5-1. F2 · price: Dr. Bhatia undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price. F3 · price: Open market sales reported on this line occurred at a weighted average price of $276.65 (range $276.21 to $276.83). Read SEC document |
| July 25, 2022 Filed Jul 27, 2022 20:17 UTC |
LEIDEN JEFFREY MDirector · Executive Chairman
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 60,342 | $0.00 Strike: $91.05 | $0.00 |
DisclosureSEC source: 0000899243-22-026840 · doc4.xml · derivative · entry 8 LEIDEN JEFFREY M · CIK 0001242825 · Director · Executive Chairman 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 33,524 Underlying: Common Stock · 60,342 shares Expires 2026-02-01 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F8 · derivative.exercise_date: Fully vested. Read SEC document |
| July 25, 2022 Filed Jul 27, 2022 20:17 UTC |
LEIDEN JEFFREY MDirector · Executive Chairman
|
SaleCommon Stock | 10,471 | $283.42 | $2,967,690.82 |
DisclosureSEC source: 0000899243-22-026840 · doc4.xml · nonDerivative · entry 6 LEIDEN JEFFREY M · CIK 0001242825 · Director · Executive Chairman 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,423 F1 · kind: Transaction made pursuant to Dr. Leiden's company approved trading plan under Rule 10b5-1. F2 · price: Dr. Leiden undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price. F7 · price: Open market sales reported on this line occurred at a weighted average price of $283.42 (range $282.90 to $283.84). Read SEC document |
| July 25, 2022 Filed Jul 27, 2022 20:17 UTC |
LEIDEN JEFFREY MDirector · Executive Chairman
|
SaleCommon Stock | 40,666 | $282.43 | $11,485,298.38 |
DisclosureSEC source: 0000899243-22-026840 · doc4.xml · nonDerivative · entry 5 LEIDEN JEFFREY M · CIK 0001242825 · Director · Executive Chairman 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 12,894 F1 · kind: Transaction made pursuant to Dr. Leiden's company approved trading plan under Rule 10b5-1. F2 · price: Dr. Leiden undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price. F6 · price: Open market sales reported on this line occurred at a weighted average price of $282.43 (range $281.90 to $282.89). Read SEC document |
| July 25, 2022 Filed Jul 27, 2022 20:17 UTC |
LEIDEN JEFFREY MDirector · Executive Chairman
|
SaleCommon Stock | 34,090 | $281.27 | $9,588,494.30 |
DisclosureSEC source: 0000899243-22-026840 · doc4.xml · nonDerivative · entry 4 LEIDEN JEFFREY M · CIK 0001242825 · Director · Executive Chairman 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 53,560 F1 · kind: Transaction made pursuant to Dr. Leiden's company approved trading plan under Rule 10b5-1. F2 · price: Dr. Leiden undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price. F5 · price: Open market sales reported on this line occurred at a weighted average price of $281.27 (range $280.90 to $281.89). Read SEC document |
| July 25, 2022 Filed Jul 27, 2022 20:17 UTC |
LEIDEN JEFFREY MDirector · Executive Chairman
|
SaleCommon Stock | 32,983 | $280.37 | $9,247,443.71 |
DisclosureSEC source: 0000899243-22-026840 · doc4.xml · nonDerivative · entry 3 LEIDEN JEFFREY M · CIK 0001242825 · Director · Executive Chairman 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 87,650 F1 · kind: Transaction made pursuant to Dr. Leiden's company approved trading plan under Rule 10b5-1. F2 · price: Dr. Leiden undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price. F4 · price: Open market sales reported on this line occurred at a weighted average price of $280.37 (range $279.90 to $280.88). Read SEC document |
| July 25, 2022 Filed Jul 27, 2022 20:17 UTC |
LEIDEN JEFFREY MDirector · Executive Chairman
|
SaleCommon Stock | 13,869 | $279.44 | $3,875,553.36 |
DisclosureSEC source: 0000899243-22-026840 · doc4.xml · nonDerivative · entry 2 LEIDEN JEFFREY M · CIK 0001242825 · Director · Executive Chairman 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 120,633 F1 · kind: Transaction made pursuant to Dr. Leiden's company approved trading plan under Rule 10b5-1. F2 · price: Dr. Leiden undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price. F3 · price: Open market sales reported on this line occurred at a weighted average price of $279.44 (range $278.90 to $279.89). Read SEC document |
| July 25, 2022 Filed Jul 27, 2022 20:17 UTC |
LEIDEN JEFFREY MDirector · Executive Chairman
|
Exercise / conversionCommon Stock | 60,342 | $91.05 | $5,494,139.10 |
DisclosureSEC source: 0000899243-22-026840 · doc4.xml · nonDerivative · entry 1 LEIDEN JEFFREY M · CIK 0001242825 · Director · Executive Chairman 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 134,502 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| July 19, 2022 Filed Jul 21, 2022 20:48 UTC |
ALTSHULER DAVIDEVP, Global Research and CSO
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 7,338 | $0.00 Strike: $155.57 | $0.00 |
DisclosureSEC source: 0000899243-22-026486 · doc4.xml · derivative · entry 8 ALTSHULER DAVID · CIK 0001550395 · EVP, Global Research and CSO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 7,338 shares Expires 2028-02-05 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F9 · derivative.exercise_date: Fully vested. Read SEC document |
| July 19, 2022 Filed Jul 21, 2022 20:48 UTC |
ALTSHULER DAVIDEVP, Global Research and CSO
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 10,427 | $0.00 Strike: $187.53 | $0.00 |
DisclosureSEC source: 0000899243-22-026486 · doc4.xml · derivative · entry 7 ALTSHULER DAVID · CIK 0001550395 · EVP, Global Research and CSO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,911 Underlying: Common Stock · 10,427 shares Expires 2029-02-05 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F8 · derivative.exercise_date: The option vests in 16 quarterly installments from 2/6/2019. Read SEC document |
| July 19, 2022 Filed Jul 21, 2022 20:48 UTC |
ALTSHULER DAVIDEVP, Global Research and CSO
|
SaleCommon Stock | 6,604 | $289.48 | $1,911,725.92 |
DisclosureSEC source: 0000899243-22-026486 · doc4.xml · nonDerivative · entry 6 ALTSHULER DAVID · CIK 0001550395 · EVP, Global Research and CSO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 36,077 F2 · kind: Transaction made pursuant to Mr. Altshuler's company approved trading plan under Rule 10b5-1. F3 · price: Mr. Altshuler undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price. F7 · price: Open market sales reported on this line occurred at a weighted average price of $289.48 (range $289.11 to $290.06). Read SEC document |
| July 19, 2022 Filed Jul 21, 2022 20:48 UTC |
ALTSHULER DAVIDEVP, Global Research and CSO
|
SaleCommon Stock | 5,737 | $288.67 | $1,656,099.79 |
DisclosureSEC source: 0000899243-22-026486 · doc4.xml · nonDerivative · entry 5 ALTSHULER DAVID · CIK 0001550395 · EVP, Global Research and CSO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 42,681 F2 · kind: Transaction made pursuant to Mr. Altshuler's company approved trading plan under Rule 10b5-1. F3 · price: Mr. Altshuler undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price. F6 · price: Open market sales reported on this line occurred at a weighted average price of $288.67 (range $288.11 to $289.09). Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.